As employers grapple with how to pay for these medications, some are exploring strategies like: Limiting coverage to patients with the highest need Pairing GLP-1 coverage with a dietician to improve nutrition, support for physical exercise and intensive behavioral health therapy Alternative payment models that hold drug manufacturers accountable for producing results GLP-1s deliver impressive clinical results but at a steep cost
[4] This inquiry largely examined the variations in levels of substance P, beta-endorphin, and corticosteronekey biomarkers relevant for decoding the stress response and the potential regulatory actions of DSIP
[CrossRef] [PubMed] [Google Scholar] Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
Addressing these metabolic demands, L-carnitine (LC), a compound involved in fatty acid oxidation, has been proposed as a promising ergogenic aid
The world's most documented pentadecapeptide, now in tablet form